AI-driven business growth accelerates: DocuSign (DOCU.US)'s second-quarter revenue increased 9.4% year over year and raised full-year results guidance

The Zhitong Finance App learned that the stock price of electronic signature solution provider DocuSign (DOCU.US) rose 7% after trading on Thursday. Previously, the company released financial results for the second quarter of fiscal year 2027 and raised its full-year revenue forecast. According to financial reports, DocuSign's revenue for the quarter reached US$875.7 million, up 9.4% year over year, exceeding expectations of US$8.54 million; adjusted earnings per share were US$1.16, higher than the market's general expectation of US$1.09.

For the quarter ending July 31, its adjusted gross margin was 81.7%, slightly higher than the forecast of 81.6%; the adjusted operating margin was 31.6%, which also exceeded expectations of 30%. GAAP earnings per share were $0.40 compared to expectations of $0.41.

Free cash flow was $295.8 million, and profit margin was 34%, compared to $2176 million in the same period last year, or 27% profit margin.

At the end of the quarter, the total amount of cash, cash equivalents, and investments held by the company was $973.1 million.

CEO Allan Thygesen said, “DocuSign is raising performance expectations as artificial intelligence is accelerating the growth momentum of the entire business.” “We have said that IAM will be the agreement's operating system, and we have delivered on that promise this quarter. Our AI agents are now able to securely execute contract workflows end-to-end, while the IAM platform also handles a record number of agreements.”

For the ongoing quarter, DocuGuide expects revenue to be between $886 million and $890 million, which is roughly in line with market expectations of $888 million.

For the full fiscal year, the company raised its revenue guidance to $3.5 billion to $3.51 billion, compared to the previous forecast of $3.49 billion to $3.5 billion. At the same time, it raised the adjusted operating margin guidance to 31% to 31.5%, compared to the previous guidance of 30.5% to 31%.